November 30, 2020
Adverse Pregnancy Outcomes Up for Women With Psoriasis
MONDAY, Nov. 30, 2020 (HealthDay News) — Pregnancies in women with psoriasis have an increased risk for adverse outcomes, including preeclampsia and stillbirth, according to a study published online Nov. 18 in the Journal of Dermatology. Yu-Heui Huang, M.D., from Chung Shan Medical University in Taichung, Taiwan, and colleagues examined maternal and fetal outcomes for...
Breast Cancer, CRC Incidence No Different With, Without MS
MONDAY, Nov. 30, 2020 (HealthDay News) — The incidence of and mortality rates for breast and colorectal cancers do not differ for individuals with and without multiple sclerosis (MS), while bladder cancer incidence and mortality rates are higher for MS patients, according to a study published online Nov. 25 in Neurology. Ruth Ann Marrie, M.D.,...
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
MONDAY, Nov. 30, 2020 (HealthDay News) — Patients with type 2 diabetes (T2D) with optimally managed risk factor control have increased cardiovascular disease (CVD) risk compared with controls without diabetes, according to a study published in the Nov. 17 issue of Circulation. Alison K. Wright, Ph.D., from the University of Manchester in the United Kingdom,...
Risk for Bone Fractures Up for Patients With Psoriatic Diseases
MONDAY, Nov. 30, 2020 (HealthDay News) — For adults with psoriatic diseases, the likelihood of developing bone fractures is increased, although they have no increased risk for osteoporosis, according to a review published online Nov. 19 in the Journal of Clinical Medicine. Tai-Li Chen, M.D., from Hualien Tzu Chi Hospital in Taiwan, and colleagues examined...
More Than Half of Cancer Patients Willing to Enroll in Clinical Trials
Participation rates similar for Black and White patients, treatment and cancer control trials More than half of patients offered participation in cancer clinical trials are willing to participate, according to a study published online Oct. 6 in the Journal of the National Cancer Institute to coincide with the ASCO Quality Care Symposium, held virtually from...
Dramatic Drop In Cancer Diagnoses Amid COVID Pandemic Is Cause For Concern (PHEN)
By Dr. Mark Abdelmalek and Lucien bruggeman At the onset of the novel coronavirus, American healthcare providers sought to limit non-essential in-person visits, opting instead to put off routine examinations – including annual cancer screenings – as part of an effort to curb risky face-to-face interactions. This precautionary approach was endorsed by the American Cancer Society,...
To Improve Research in Underserved Communities, Train Community Health Workers
New grant allows for improved training of community health workers to engage minority populations in research where they are often underrepresented and health disparities exist. Community health workers are an important resource for providing basic health care needs for the community, as well as helping facilitate clinical research. “We know that community health workers are...
Clinical Trial Offers Clues About Why Some Metastatic Prostate Cancers Don’t Respond to Anti-Androgen Therapy
Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment. Over the last decade, enzalutamide and similar drugs have led to significant tumor control and increased survival time for men who have metastatic prostate cancer that continues to grow despite treatments to reduce male hormone levels. About...
Prostate Cancer Trial Participants Overwhelmingly White
Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80 percent Prostate cancer clinical trial participants are overwhelmingly white, according to a study published online June 5 in Cancer Epidemiology, Biomarkers & Prevention. Emily M. Rencsok, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues analyzed 72 global...